Acadian Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21K | Sell |
44
-437
| -91% | -$224K | ﹤0.01% | 1949 |
|
|
2025
Q4 | $268K | Hold |
481
| – | – | ﹤0.01% | 1462 |
|
|
2025
Q3 | $246K | Sell |
481
-587
| -55% | -$256K | ﹤0.01% | 1366 |
|
|
2025
Q2 | $335K | Sell |
1,068
-416
| -28% | -$125K | ﹤0.01% | 1216 |
|
|
2025
Q1 | $452K | Sell |
1,484
-652
| -31% | -$219K | ﹤0.01% | 1103 |
|
|
2024
Q4 | $708K | Sell |
2,136
-3,033
| -59% | -$1.03M | ﹤0.01% | 993 |
|
|
2024
Q3 | $1.72M | Sell |
5,169
-5,401
| -51% | -$2.05M | 0.01% | 783 |
|
|
2024
Q2 | $4.35M | Sell |
10,570
-13,375
| -56% | -$5.3M | 0.01% | 538 |
|
|
2024
Q1 | $9.67M | Sell |
23,945
-31,514
| -57% | -$11.1M | 0.03% | 310 |
|
|
2023
Q4 | $17M | Buy |
55,459
+3,531
| +7% | +$953K | 0.07% | 226 |
|
|
2023
Q3 | $12.6M | Sell |
51,928
-23,839
| -31% | -$6.1M | 0.05% | 254 |
|
|
2023
Q2 | $18.2M | Sell |
75,767
-56,802
| -43% | -$11.8M | 0.07% | 226 |
|
|
2023
Q1 | $24.9M | Buy |
132,569
+2,510
| +2% | +$519K | 0.11% | 202 |
|
|
2022
Q4 | $27.6M | Buy |
130,059
+128,060
| +6,406% | +$25.6M | 0.14% | 168 |
|
|
2022
Q3 | $313K | Buy |
+1,999
| New | +$319K | ﹤0.01% | 1107 |
|
|
2022
Q1 | – | Sell |
-3,129
| Closed | -$680K | – | 1732 |
|
|
2021
Q4 | $680K | Hold |
3,129
| – | – | ﹤0.01% | 925 |
|
|
2021
Q3 | $592K | Sell |
3,129
-10,471
| -77% | -$1.91M | ﹤0.01% | 998 |
|
|
2021
Q2 | $2.4M | Sell |
13,600
-115,671
| -89% | -$20M | 0.01% | 661 |
|
|
2021
Q1 | $21.2M | Sell |
129,271
-51,515
| -28% | -$7.88M | 0.08% | 212 |
|
|
2020
Q4 | $25.2M | Sell |
180,786
-51,652
| -22% | -$6.51M | 0.1% | 177 |
|
|
2020
Q3 | $26M | Sell |
232,438
-158,607
| -41% | -$18.3M | 0.11% | 173 |
|
|
2020
Q2 | $36.4M | Sell |
391,045
-71,647
| -15% | -$6.1M | 0.16% | 150 |
|
|
2020
Q1 | $34M | Sell |
462,692
-67,365
| -13% | -$5.85M | 0.19% | 118 |
|
|
2019
Q4 | $44.6M | Sell |
530,057
-636,950
| -55% | -$49.3M | 0.2% | 117 |
|
|
2019
Q3 | $98.1M | Sell |
1,167,007
-69,893
| -6% | -$5.28M | 0.42% | 64 |
|
|
2019
Q2 | $80.9M | Sell |
1,236,900
-48,777
| -4% | -$2.81M | 0.39% | 68 |
|
|
2019
Q1 | $75.8M | Sell |
1,285,677
-69,974
| -5% | -$4.18M | 0.33% | 81 |
|
|
2018
Q4 | $71.8M | Sell |
1,355,651
-108,470
| -7% | -$5.95M | 0.36% | 80 |
|
|
2018
Q3 | $87.7M | Buy |
1,464,121
+182,588
| +14% | +$9.99M | 0.36% | 79 |
|
|
2018
Q2 | $55.1M | Buy |
1,281,533
+282,216
| +28% | +$11.4M | 0.24% | 99 |
|
|
2018
Q1 | $34.9M | Buy |
999,317
+365,574
| +58% | +$13.4M | 0.15% | 141 |
|
|
2017
Q4 | $23M | Buy |
633,743
+40,944
| +7% | +$1.44M | 0.1% | 177 |
|
|
2017
Q3 | $18.9M | Buy |
592,799
+107,161
| +22% | +$3.27M | 0.08% | 208 |
|
|
2017
Q2 | $14.1M | Buy |
485,638
+154,331
| +47% | +$4.33M | 0.06% | 236 |
|
|
2017
Q1 | $9.89M | Buy |
+331,307
| New | +$10.7M | 0.05% | 287 |
|
Other funds holding MEDP
VPM
VCM
WA
Acadian Asset Management's MEDP Position: Q1 2026 in Review
Acadian Asset Management reduced its Medpace (MEDP) stake by 91% in Q1 2026, selling an estimated $224K and leaving 44 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1949.
Acadian Asset Management first reported a position in MEDP in Q1 2017 and has held it in 35 quarters since. The position peaked at $98.1M in Q3 2019. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Acadian Asset Management held 44 shares of Medpace worth $21K as of Q1 2026.
- Acadian Asset Management sold 437 Medpace shares in Q1 2026, an estimated $224K.
- Medpace made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1949 holding.
- Acadian Asset Management first reported a position in Medpace in Q1 2017 and has held it in 35 quarters since.
- Acadian Asset Management's Medpace position peaked at $98.1M in Q3 2019.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.